From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis
Characteristics | Total(N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
Age | 4929 | Â | Â | Â | Â |
 <  = 60 | 2464 | Reference |  |  |  |
 > 60 | 2465 | 1.125 (0.832–2.056) | 0.127 | 1.245(0.796–2.214) | 0.414 |
T stage | 4920 | Â | Â | Â | Â |
T1 | 1274 | Reference | Â | Â | Â |
T2&T3&T4 | 3646 | 1.315 (1.007–2.731) | 0.052 | 1.373 (0.826–3.134) | 0.125 |
N stage | 4894 | Â | Â | Â | Â |
N0 | 2143 | Reference | Â | Â | Â |
N1&N2&N3 | 2751 | 2.215 (2.222–5.194) |  < 0.001 | 2.853 (1.321–5.317) | 0.013 |
M stage | 4801 | Â | Â | Â | Â |
M0 | 4637 | Reference | Â | Â | Â |
M1 | 164 | 6.153 (3.064–12.612) |  < 0.001 | 5.132 (3.428–13.241) |  < 0.001 |
Pathologic stage | 4887 | Â | Â | Â | Â |
Stage I | 1035 | Reference | Â | Â | Â |
Stage II&Stage III&Stage IV | 3852 | 3.491 (1.613–7.423) | 0.007 | 1.307 (0.403–3.459) | 0.749 |
ER status | 4872 | Â | Â | Â | Â |
Negative | 938 | Reference | Â | Â | Â |
Positive | 3934 | 0.459 (0.313–0.725) | 0.003 | 0.413 (0.213–0.728) | 0.045 |
PR status | 4860 | Â | Â | Â | Â |
Negative | 1104 | Reference | Â | Â | Â |
Positive | 3756 | 0.617 (0.414–0.876) | 0.017 | 0.834 (0.414–1.625) | 0.407 |
HER2 status | 4507 | Â | Â | Â | Â |
Negative | 3754 | Reference | Â | Â | Â |
Positive | 753 | 1.603 (0.629–2.714) | 0.315 |  |  |
radiation_therapy | 4736 | Â | Â | Â | Â |
No | 1975 | Reference | Â | Â | Â |
Yes | 2761 | 0.691 (0.315–1.176) | 0.453 |  |  |
HSPB1 | 4929 | Â | Â | Â | Â |
Low | 2464 | Reference | Â | Â | Â |
High | 2465 | 1.479 (1.124–1.893) | 0.038 |  |  |